Hormone Replacement Therapy Linked to Reduced Bone Loss in Menopause, Study Suggests

Women in menopause have long avoided hormone replacement therapy (HRT) due to outdated concerns, but recent research underscores its critical role in preserving bone health, according to a 2023 study published in *Cureus*. The findings highlight HRT’s effectiveness in mitigating bone mineral density loss, a key risk factor for osteoporosis and fractures.

What Did the Study Find?

A study led by Diego Espinoza, MD, a researcher at Investigación Médica Sonora, analyzed data from 387 postmenopausal women who underwent dual-energy X-ray absorptiometry (DXA) scans between 2021 and 2025. Women using menopausal hormone therapy had a 69% lower risk of low bone mineral density in the spine and hip compared to those who did not, even after accounting for factors like age, smoking, and vitamin D levels. The results were presented at the Endocrine Society’s annual meeting in 2023.

Why Does Hormone Therapy Support Bone Health?

Estrogen plays a central role in maintaining bone density by regulating bone remodeling, the process where old bone tissue is replaced by new. During menopause, declining estrogen accelerates bone loss, increasing fracture risk. HRT replenishes these hormones, slowing bone turnover and preserving mineral density, as explained by Espinoza. “Our findings align with established biological understanding, showing HRT improves skeletal outcomes in clinical practice,” he said.

Can HRT Be Prescribed for Bone Health?

Yes, HRT is FDA-approved for preventing bone loss and reducing osteoporosis risk, according to Lauren Streicher, MD, a menopause specialist. “It’s been known for years that HRT decreases low bone mass,” she noted. Mary Jane Minkin, MD, a Yale professor, emphasized that HRT is most effective for bone protection if initiated within four years of menopause. “Low estrogen doses can still prevent bone loss,” she added.

What Are Alternatives to HRT for Bone Health?

While HRT is effective, lifestyle factors remain vital. Ruthann Devera, MD, an OB-GYN, stressed the importance of weight-bearing exercise, calcium and vitamin D intake, and avoiding smoking. “For women considering HRT for symptoms, bone protection is an added benefit,” she said. Other treatments, like bisphosphonates, are also used but may carry different risks.

What Are the Risks of HRT?

HRT is not without controversy. The 2002 Women’s Health Initiative study linked it to increased breast cancer and cardiovascular risks, though newer formulations and personalized approaches have reduced these concerns. “Risks vary by individual, and benefits often outweigh risks for women with significant symptoms or bone loss,” said Minkin.

How Does HRT Compare to Other Treatments?

A 2022 review in *The Journal of Clinical Endocrinology & Metabolism* found HRT to be more effective than bisphosphonates in preserving bone density over five years. However, long-term HRT use requires careful monitoring. “Patients should discuss their options with a healthcare provider to weigh benefits and risks,” said Streicher.

What’s Next for HRT Research?

Future studies aim to refine HRT dosing and identify biomarkers to predict individual responses. Espinoza’s team plans to track participants long-term to assess fracture rates. “Personalized approaches will shape the next era of menopause care,” he said.

Key Takeaways

• HRT reduces bone mineral density loss by 69% in postmenopausal women, per a 2023 study.
• Estrogen’s role in bone remodeling makes HRT effective for preventing osteoporosis.
• HRT is most beneficial when started within four years of menopause.
• Lifestyle changes and alternative medications also support bone health.
• Risks vary by individual, requiring personalized medical consultation.

For women considering HRT, consulting a healthcare provider to evaluate risks and benefits is essential. As research continues to evolve, HRT remains a cornerstone of menopause management for bone health.